The dietary flavonoid quercetin is an antioxidant that possesses anti-inflammatory and anticarcinogenic properties and may modulate signaling pathways. Inflammation is considered to play a pivotal role in carcinogenesis by triggering activation of transcription factors such as NF-κB, functionally dependent on cellular redox status.
Introduction
Consumption of fruits and vegetables has been connected to a reduced risk of chronic diseases, such as cancer (1), and many studies have demonstrated that one of the more active family of phytochemicals in these fruits and vegetables is that of polyphenols (1).
The flavonol quercetin is the most common plant-derived flavonoid in the diet (1), and it is extensively metabolized in the small intestine and in the liver (2) . Quercetin possesses antioxidant properties (3), potential anti-proliferative and anticarcinogenic activities (4) (5) (6) , and it is a potent anti-inflammatory agent (7) (8) (9) (10) .
A causal relationship between inflammation and cancer has long been suspected (11) .
Epidemiological studies suggest that major risk factors for hepatocelullar carcinoma are persistent infection with hepatitis B and C virus and exposure to genotoxic and cytotoxic chemicals, all of which cause inflammation (12) . It has been described that in this inflammatory process, the vast majority of cellular events require the nuclear factorkappa B (NF-κB) activation (11, 12) . However, the molecular mechanisms linking chronic inflammation and cancer are not well known yet.
NF-κB is a transcription factor that regulates inflammation, immunity, apoptosis, cell proliferation and differentiation after binding to DNA and activating gene transcription (13, 14) . NF-κB is activated by a wide variety of inflammatory stimuli, including tumor necrosis factor α (TNF), interleukin-1 (IL-1), lipopolysaccharide (LPS) or H 2 O 2 . The cytokine TNF plays an important role in initiating and perpetuating NF-κB signaling and chronic inflammation (15) . Stimulation of cells with pro-inflammatory agents causes the activation of inhibitor of κB (IκB) kinase (IKK), which in turn phosphorylates and degrades IκBα and leads to NF-κB translocation to the nucleus and binding to a specific DNA consensus sequence; all this results in the transcriptional activation of NF-κB regulated genes involved in inflammation such as cyclooxygenase-
(COX-2) (13).
COX-2 promoter is known to contain a NF-κB binding site, essential for the induction of this inflammatory enzyme that is activated in response to TNF (15) . COX-2 catalyses the production of inflammatory mediators such as prostagladins and is persistently overexpressed in chronic liver inflammation and cirrhosis, as well as in experimental and human hepatocellular carcinoma (16, 17). COX-2 could be locally induced by proinflammatory mitogens, cytokines and growth factors during inflammation and carcinogenesis, suggesting that COX-2 may play a role in hepatocarcinogenesis (17).
In addition, the induction of NF-κB activity by TNF can also be modulated by MAPKs, such as JNK, ERK, p38 and the PI3K/AKT pathway (15) . Activation of these molecular routes depends in most cases on the production of reactive oxygen species (ROS) (18).
In this regard, increased production of ROS is a common feature in both cancer and inflammation and it can stimulate the NF-κB pathway (18).
Recently, several studies have demonstrated that quercetin and other polyphenols suppress a number of key elements in cellular signal transduction pathways resulting in the inhibition of pro-inflammatory mediators (7, 9, 10, (19) (20) (21) . Thus, quercetin and other phenolic compounds show anti-inflammatory effects through the down-regulation of the NF-κB pathway (7) (8) (9) (10) (19) (20) (21) (22) , although no effects on NF-κB activation has been occasionally reported (23). However, the detailed molecular mechanism of action of this phenolic compound to modulate the NF-κB pathway and COX-2 expression in liver cells during an inflammatory process is still poorly understood.
The present study is aimed to test whether the anti-inflammatory effect of quercetin is mediated through the modulation of the NF-κB pathway, COX-2 and members of
MAPKs family. Results demonstrate that quercetin is a potent inhibitor of the TNF-stimulated NF-κB pathway, which is mediated at least in part by the inhibition of ERKand JNK-MAPKs. Quercetin also inhibits TNF-induced inflammatory enzyme COX-2 and intracellular ROS generation.
Materials and methods

Materials and chemicals
Quercetin, 6-diamidino-2-phenylindole (DAPI), gentamicin, penicillin G and streptomycin were purchased from Sigma Chemical (Madrid, Spain). Anti-ERK1/2 and anti-phospho-ERK1/2 recognizing phosphorylated Thr202/Thy204 of ERK1/2, anti- 
Cell culture and quercetin treatment
Human hepatoma HepG2 cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) F-12 medium, supplemented with 2.5% fetal bovine serum (FBS) and antibiotics (50 mg/L gentamicin, 50 mg/L penicillin and 50 mg/L streptomycin). Cells were maintained at 37ºC in a humidified atmosphere of 5% CO 2 .
Cells were changed to serum-free medium 24 h before the assay in order to avoid the influence of the growth factors contained in the FBS on the results. To study the effects of the flavonoid, cells were treated with different concentrations of quercetin (0.1, 0.5, 1, 5 and 10 M) and then harvested at 4 h.
To study the effects of TNF, HepG2 cells were incubated with TNF (6 ng/mL) and harvested at different times (15, 30, 45 and 60 min). Additionally, in some cases after quercetin treatment cells were stimulated with TNF (6 ng/mL) for 30 min.
Preparation of total cell lysates
To detect ERK1/2, phospho-ERK1/2, JNK and phospho-JNK, cells were lysed at 4ºC in a buffer containing 25 mM N-2-hydroxyethylpiperazine-N´-2-ethanesulfonic acid (HEPES) (pH 7.5), 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM ethylendiaminetetraacetic acid (EDTA), 0.5 mM dithiothreitol (DTT), 0.1% Triton X-100, 200 mM β-glycerolphosphate, 0.1 mM Na 3 VO 4 , 2 μg/mL leupeptin and 1 mM phenylmethylsulfonyl fluoride (PMSF). The supernatants were collected, assayed for protein concentration by using the Bio-Rad (Madrid, Spain) protein assay kit according to the manufacture´s specifications, aliquoted and stored at -80ºC until use for Western blot analyses.
Preparation of nuclear and cytosolic extracts
Cells were resuspended at 4°C in 10 mM HEPES pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, 0.2 mM PMSF (buffer A), allowed to swell on ice for 10 min, and then vortexed for 10 s. Samples were centrifuged at 10.000g for 2 min and the supernatant containing the cytosolic fraction was stored at -80°C. The pellet was resuspended in cold buffer B (20 mM HEPES pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF, 2.5 μg/mL leupeptin, 2.5 μg/mL aprotinin) and incubated on ice for 20 min for high salt extraction. Cellular debris was removed by centrifugation at 13.000g for 10 min at 4°C, and the supernatant fraction containing nuclear protein extract was stored at -80°C. Cytosolic and nuclear proteins were measured using the protein reagent following the recommendations of the supplier, aliquoted and stored at -80ºC until used for Western blot and ELISA analyses.
Western blot analysis
Equal amounts of proteins (100 μg) were separated by SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride (PVDF) filters (Protein Sequencing Membrane, Bio-Rad, Madrid, Spain). Membranes were probed with the corresponding primary antibody followed by incubation with peroxide-conjugated antirabbit immunoglobulin (GE Healthcare, Madrid, Spain). Blots were developed with the ECL system (GE Healthcare, Madrid, Spain). Equal loading of Western blot was ensured by β-actin and bands were quantified using a scanner and accompanying software.
Measurement of the NF-κB DNA binding activity
The DNA binding of NF-κB was measured with a colorimetric non-radioactive NF-κB Transcription Factor ELISA Assay (Active Motif, Rixensart, Belgium) according to the manufacturer's instructions. Briefly, nuclear extracts were incubated in the oligonucleotide-coated wells. Then, wells were washed and incubated with the antibody against NF-κB (p65). Addition of the secondary antibody conjugated to horseradish peroxidase provided a colorimetric readout. The absorbance of each well was measured using a microplate reader at 450nm (Bio-Tek, Winooski, VT, USA).
Immunofluorescence assay was performed as previously described (24). Briefly, HepG2 cells were seeded (25.000 cells/well) on glass coverslips with DMEM F-12 supplemented with FBS for 24 h and changed to serum-free medium 24 h before the assay. After incubation with quercetin and/or TNF for the indicated times, cells were washed with PBS at room temperature and then fixed with 3.7% paraformaldehyde for 10 min at room temperature. Cells were rinsed with PBS, permeabilized with ice-cold acetone and subsequently blocked with 1% BSA. Cells were incubated with the corresponding primary antibody and then incubated with the anti-rabbit Alexa Fluor-594 conjugated secondary antibody. Nuclei were visualized by using DAPI staining.
The coverslips were mounted in Vectashield and images were taken with a Zeiss Axiovert 200M immunofluorescence microscope (Carl Zeiss Microimaging GmbH, Munich, Germany) at 63x magnification. AxioVisionRel 4.6 software was used for images analysis.
Cell viability assay
Cell viability was determined using the crystal violet assay (5). HepG2 cells were seeded at low density (10 4 
Determination of reactive oxygen species (ROS)
Cellular oxidative stress was quantified by the dichlorofluorescin (DCFH) assay using a microplate reader (4). Briefly, 5 M DCFH was added to the wells (2x10 
Statistics
Prior to statistical analysis, data were tested for homogeneity of variances by the test of Levene; for multiple comparisons, one-way ANOVA was followed by the Bonferroni test when variances were homogeneous or by the Tamhane test when variances were not homogeneous. P<0.05 was considered significant. A SPSS version 17.0 program was used.
Results
To establish a model for the study of the effect of quercetin on the NF-κB pathway in HepG2 cells, we first checked the direct effect on the NF-κB pathway after 4 h treatment of cells with the flavonoid. Later, we established the time-point for further studies on the effect of quercetin on the NF-κB pathway to study the effect of TNF (6 ng/mL) stimulating NF-κB in HepG2 cells at different times.
Quercetin does not affect the NF-κB pathway
To assess whether quercetin alone affects the NF-κB pathway, the effect of the flavonoid on p-IκB, IκB, IKK and NF-κB protein levels were evaluated after 4 h of incubation with different concentrations of the polyphenol. As shown in Figures 1A and 1B, quercetin did not modify any of the mentioned protein levels and it did not affect the translocation of NF-кB, as the nuclear and cytosolic levels of this transcription factor remain unchanged after the flavonoid incubation. Additionally, it should be mentioned that no cytotoxicity and no effect on cell proliferation were observed in quercetin-treated cells at 24 h with any of the flavonoid concentrations tested (data not shown).
TNF induces NF-κB and IKK activation
TNF is one of the most potent activators of NF-κB, but the mechanism of activation of NF-κB is not fully established. Thus, the effect of TNF (6 ng/mL) through time to stimulate NF-κB in HepG2 cells was analyzed. TNF early activated NF-κB (15-30 min), as shown by the remarkable enhancement in the relative amount of nuclear versus cytosolic NF-кB levels, followed by a decrease to control levels at 60 min (Figures 2A-2C ). Therefore, 30 min time, which showed the highest activation of NF-κB was selected as standard treatment to activate NF-κB in HepG2 cells.
Since TNF induces NF-κB activation, the regulation of upstream members of the NF-κB signaling pathway was next investigated. Similar to the activation profile of NF-κB, TNF induced an increase in the nuclear/cytosolic IKK ratio, which was maximum after 30 min of incubation, later recovering control levels (60 min) (Figures 2A and 2B ).
The concentration of TNF used and the time of exposure had no effect on the viability of the cells (data not shown).
Quercetin inhibits TNF-induced NF-κB and IKK activation
The effect of quercetin on TNF-induced NF-κB activation was studied in HepG2 cells preincubated for 4 h with different concentrations of quercetin and then treated with TNF (6 ng/mL) for 30 min. Results in Figures 3A and 3B shows that the flavonoid abolished the TNF-dependent activation of NF-κB.
To further confirm the effect of quercetin pretreatment on the suppression of nuclear translocation of NF-κB, an immunocytochemistry assay was performed. As shown in Figure 3C , after 30 min of incubation TNF clearly induced nuclear translocation of p65-NF-κB, whereas pretreatment with quercetin suppressed its translocation to the nucleus, in agreement with the Western blot results ( Figures 3A and 3B ).
Correspondingly to NF-κB, quercetin incubation suppressed the TNF-induced IKK levels, resulting in the inhibition of IKK translocation in a concentration-dependent manner ( Figures 3A and 3B ).
The concentration of quercetin and TNF used and the time of exposure had no effect on the viability of the cells (data not shown).
Quercetin inhibits NF-κB DNA binding activity
To determine whether quercetin blocks NF-κB activation by interfering with its binding to DNA, nuclear extracts were prepared from quercetin-pretreated cells, incubated with 6 ng/mL TNF for 30 min and then examined for their ability to bind to DNA. Figure 3D shows that TNF treatment highly increased the binding of NF-κB to the DNA, and that quercetin pretreatment caused a dose-dependent reduction on DNA binding of this transcription factor.
Quercetin inhibits TNF-dependent IB phosphorylation
IB is phosphorylated by IKK (13), and we have demonstrated that quercetin diminished TNF-induced IKK levels in a dose-dependent manner, then the effect of quercetin pretreatment and later incubation with TNF (6 ng/mL) on IB phosphorylation was determined. TNF induced IB phosphorylation, showed maximum levels after 30 min of incubation, followed by a decrease to values comparable to untreated cells at 45 and 60 min ( Figures 4A and 4B ).
Quercetin pretreatment suppressed the TNF-induced IB phosphorylation, recovering control values after 10 M quercetin incubation ( Figures 4C and 4D ).
Quercetin inhibits TNF-dependent IB degradation
Translocation of NF-κB to the nucleus is preceded by the proteolytic degradation of IB (13) . Thus, TNF incubation caused a rapid reduction of IB levels (15-30 min) to later return to control levels after 45 min of treatment onwards ( Figures 4A and 4B ).
To determine whether quercetin inhibition of TNF-induced NF-κB activation was due to inhibition of IB degradation, cells were pretreated with the flavonoid for 4 h, then exposed to TNF for 30 min and IB levels analyzed. Quercetin induced a restoration in IB levels, although IB control values were not totally reached even with the highest concentration of quercetin (10 M) ( Figures 4C and 4D ).
Quercetin attenuates ROS overproduction induced by TNF
NF-κB activation is also related to ROS production (18). Accordingly, HepG2 cells were treated with different quercetin concentrations for 4 h and then exposed to TNF (6 ng/mL) for 30 min. As shown in Figure 5 , cells incubated with TNF showed an increased ROS production, whereas DCF fluorescence intensity significantly dropped in the presence of 0.5-10 M quercetin, reaching values even lower that those of untreated control cells.
Quercetin represses TNF-induced COX-2 levels
A number of studies have demonstrated that quercetin and other polyphenols show antiinflammatory effects through downregulation of COX-2 (7, 22) . It is also known that this inducible enzyme contributes to the pathogenesis of various inflammatory diseases and tumor growth (16, 17). Therefore, it was considered relevant to assess whether quercetin alone affects COX-2 protein and the effect of the flavonoid on its levels was evaluated after 4 h of incubation with different concentrations of the polyphenol. As shown in Figures 6A and 6B , 5-10 M quercetin diminished COX-2 protein levels.
COX-2 is activated in response to TNF by NF-κB (15). Thus, it was investigated whether quercetin pretreatment can suppress COX-2 protein levels. As shown in Figures 7C and 7D ).
Quercetin also inhibited the TNF-induced activation of ERK in a dose-dependent manner to reach control values at 5 and 10 M quercetin ( Figures 7C and 7D ). Total ERK and JNK protein levels did not change during Q plus TNF exposure.
Discussion
Quercetin is commonly consumed in the diet and a large body of evidence indicates that it possesses a variety of biological activities including antioxidant (3), antiproliferative (4-6), and anti-inflammatory (7, 10) . Inappropriate modulation of NF-κB, which is a major molecular coordinator of inflammatory responses (11) (12) (13) (14) , has been associated with various pathological conditions including cancer, and constitutes one of the key pathways affecting the development of many chronic diseases (12) (13) (14) . We have found that TNF rapidly causes In summary, the present study demonstrates that quercetin inhibits TNF-induced COX-2 and NF-κB pathway, which suggests that this flavonoid may act as an anti-inflammatory agent in the liver. The inhibitory effect of quercetin on the TNF-induced NF-κB activation is mediated, at least in part, by modulation of ROS generation, ERK and JNK. 
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